polypeptide nafarelin http://purl.bioontology.org/ontology/MESH/D017274 http://purl.bioontology.org/ontology/SNOMEDCT/109046009 http://purl.obolibrary.org/obo/CHEBI_7445 http://purl.obolibrary.org/obo/NCIT_C61613 https://en.wikipedia.org/wiki/Nafarelin https://www.wikidata.org/wiki/Q3869873 A gonadotropin-releasing hormone agonist (GnRH agonist) medication which is used in the treatment of endometriosis and early puberty. It is also used to treat uterine fibroids, to control ovarian stimulation in in vitro fertilization (IVF), and as part of transgender hormone therapy. A potent synthetic agonist of gonadotropin-releasing hormone with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central precocious puberty and endometriosis. gonadotropin-releasing hormone analog